Indian online pharmacy PharmEasy’s valuation drops to US$456 million


PharmEasy's valuation fell despite an IPO that raised more than $200 million in 2025.

Leave a Reply

Your email address will not be published.

Previous Story

IndiQube, a shared office company planning an initial public offering, will see its losses expand 72% in fiscal year 2024

Next Story

Global sales of Chinese electric vehicles are expected to nearly double by 2025

Don't Miss